[Panuveitis following intravesical bacille Calmette-Guerin therapy].
Uveitis occurring after bacille Calmette-Guerin (BCG) intravesical therapy for bladder carcinoma is rare: only nine cases have been described. In two previous reports, vitreous cultures proved Mycobacterium bovis presence. We describe the case of an 85-year-old woman who presented with bilateral panuveitis 2 months after the last BCG intravesical instillation, with no other systemic symptom. There was no evidence for any other etiology for this uveitis. She was given oral antibiotics that were effective against Mycobacterium species, oral steroids, and anti-inflammatory drops. Her ophthalmologic status dramatically improved. This case highlights that these patients may have a good visual outcome, as long as diagnosis and treatment are not delayed.
Jacob
M
M
Service d'Ophtalmologie, Hôpital de la Croix-Rousse, Lyon.
Gambrelle
J
J
Fleury
J
J
Durieu
I
I
Kodjikian
L
L
Duquesne
N
N
Grange
J D
JD
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000283:Administration, Intravesical; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015864:Panuveitis / Q000139:chemically induced*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine